These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16539718)

  • 1. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.
    Dewan PK; Grinsdale J; Liska S; Wong E; Fallstad R; Kawamura LM
    BMC Infect Dis; 2006 Mar; 6():47. PubMed ID: 16539718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Mycobacterium tuberculosis using an interferon-gamma release assay.
    Simpson T; Fox J; Crouse K; Field K
    J Public Health Manag Pract; 2012; 18(4):E19-25. PubMed ID: 22635200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay.
    Leyten EM; Prins C; Bossink AW; Thijsen S; Ottenhoff TH; van Dissel JT; Arend SM
    Eur Respir J; 2007 Jun; 29(6):1212-6. PubMed ID: 17215314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O; Schwartzman K; Menzies D
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak.
    Song Q; Guo H; Zhong H; Liu Z; Chen X; Wang C; Touzjian N; Lv Y; Lu X; Wang Q
    Int J Infect Dis; 2012 Jul; 16(7):e522-6. PubMed ID: 22542006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection.
    Ferrara G; Losi M; Meacci M; Meccugni B; Piro R; Roversi P; Bergamini BM; D'Amico R; Marchegiano P; Rumpianesi F; Fabbri LM; Richeldi L
    Am J Respir Crit Care Med; 2005 Sep; 172(5):631-5. PubMed ID: 15961696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay.
    Machado A; Emodi K; Takenami I; Finkmoore BC; Barbosa T; Carvalho J; Cavalcanti L; Santos G; Tavares M; Mota M; Barreto F; Reis MG; Arruda S; Riley LW
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):446-53. PubMed ID: 19335949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
    Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
    Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
    Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
    Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.